Lucid Diagnostics regains Nasdaq compliance

Lucid Diagnostics (LUCD) announced that it has received written notification from the Listings Qualifications Department of the Nasdaq Stock Market that the company has regained compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market.